Literature DB >> 10383778

The spectrum of epidermal nevi: a case of verrucous epidermal nevus contiguous with nevus sebaceus.

K M Waltz1, K F Helm, E M Billingsley.   

Abstract

During the normal development of skin, pluripotential cells give rise to keratinocytes, sebaceous glands, hair follicles, apocrine glands, and eccrine glands. In epidermal nevi, these components emerge in an abnormal mixture within a circumscribed site. Many authors have categorized epidermal nevi based on their predominant component; however, there is often notable overlap that occurs within a single area or within contiguous areas. We report a verrucous epidermal nevus contiguous to a nevus sebaceus of Jadassohn. The categories of epidermal nevi are somewhat artificial. Our case supports the view that epidermal nevi have a spectrum of manifestations, including verrucous epidermal nevi and nevus sebaceus of Jadassohn.

Mesh:

Year:  1999        PMID: 10383778     DOI: 10.1046/j.1525-1470.1999.00056.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Oral findings in a patient with Sebaceous Nevi - A Case Report.

Authors:  Vidya Baliga; V P K Gopinath; Sudhindra Baliga; Umesh Chandra
Journal:  J Int Oral Health       Date:  2013-10-26

2.  Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies.

Authors:  Aude Beyens; Laure Dequeker; Hilde Brems; Sandra Janssens; Hannes Syryn; Anne D'Hooghe; Pascale De Paepe; Lieve Vanwalleghem; Annelies Stockman; Elena Vankwikelberge; Sofie De Schepper; Marleen Goeteyn; Patricia Delbeke; Bert Callewaert
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

3.  Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.

Authors:  Jonathan L Levinsohn; Li C Tian; Lynn M Boyden; Jennifer M McNiff; Deepak Narayan; Erin S Loring; Duri Yun; Jeffrey L Sugarman; John D Overton; Shrikant M Mane; Richard P Lifton; Amy S Paller; Annette M Wagner; Richard J Antaya; Keith A Choate
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.